Latest Market Suspension News

NT Minerals has agreed to sell its Redbank and Wollogorang copper projects to Golden Horse Minerals for $3 million in combined cash and equity, shifting its strategic focus to other critical mineral assets.

Trigg Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant capital raise, signaling potential shifts in its financial strategy.

Tigers Realm Coal’s ongoing efforts to divest its Russian mining assets have hit a significant impasse amid geopolitical tensions, regulatory hurdles, and a stalled sale agreement, leaving the company suspended from ASX trading.

Hawsons Iron Limited has voluntarily suspended trading on the ASX as it prepares to announce a proposed capital raising, signaling a pivotal moment for the iron ore miner.

Vinyl Group has applied to the Federal Court for an extension to lodge delayed cleansing notices, aiming to lift its ASX trading suspension. The court hearing is set for 5 June 2025, with market watchers awaiting the outcome.

Rare Foods Australia Limited has requested an immediate suspension of its shares on the ASX, paving the way for its voluntary removal from the exchange next month. This move follows shareholder approval earlier this year.

Wellnex Life Limited’s shares have been suspended from trading on the ASX pending a response to regulatory queries, stirring investor uncertainty.

Mount Burgess Mining NL has voluntarily suspended trading of its shares on the ASX pending a court ruling on the validity of a recent cleansing notice tied to new share issuance.

Austral Resources Australia Ltd reports key operational milestones including completion of Anthill West Pit mining and a strategic MOU with New Frontier Minerals, while progressing its recapitalisation and equity raise plans.

Health and Plant Protein Group Limited has dramatically reduced its half-year net loss to $43,000 following the divestment of its macadamia division, though uncertainty lingers over a significant IRS receivable in the US.

Acorn Capital Investment Fund’s shares were suspended following a late submission of its January 2025 Net Tangible Asset Statement, attributed to human error. The company has assured shareholders the issue is resolved and trading resumed promptly.

Arovella Therapeutics has requested a voluntary suspension of its ASX-listed securities pending a material announcement on a capital raising, expected by 17 February 2025.